000 | 01083 a2200301 4500 | ||
---|---|---|---|
005 | 20250516192057.0 | ||
264 | 0 | _c20141201 | |
008 | 201412s 0 0 eng d | ||
022 | _a1540-0514 | ||
024 | 7 |
_a10.1097/SHK.0000000000000124 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPereira, Adriano José | |
245 | 0 | 0 |
_aShould we aim at high blood pressure targets in patients with cardiogenic shock? _h[electronic resource] |
260 |
_bShock (Augusta, Ga.) _cApr 2014 |
||
300 |
_a365-6 p. _bdigital |
||
500 | _aPublication Type: Editorial; Comment | ||
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMyocardial Infarction _xcomplications |
650 | 0 | 4 |
_aNorepinephrine _xtherapeutic use |
650 | 0 | 4 |
_aOxygen Consumption _xdrug effects |
650 | 0 | 4 |
_aShock, Cardiogenic _xdrug therapy |
650 | 0 | 4 |
_aVasoconstrictor Agents _xtherapeutic use |
700 | 1 | _aDe Backer, Daniel | |
773 | 0 |
_tShock (Augusta, Ga.) _gvol. 41 _gno. 4 _gp. 365-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/SHK.0000000000000124 _zAvailable from publisher's website |
999 |
_c23454678 _d23454678 |